Pasar al contenido principal

ESTUDIO DE LOS FACTORES QUE ORGANIZAN EL CROMOSOMA DE STREPTOCOCCUS PNEUMONIAE: NUEVAS DIANAS DE ANTIBIOTICOS Y MECANISMOS DE RESISTENCIA.

BIO2017-82951-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Reactive Oxygen Species Production Is a Major Factor Directing the Postantibiotic Effect of Fluoroquinolones in Streptococcus pneumoniae

  • García Esteban, María Teresa
  • Valenzuela, Myriam Victoria
  • Ferrándiz, María José
  • Gonzalez de la Campa, Adela
We studied the molecular mechanisms involved in the postantibiotic effect of the fluoroquinolones levofloxacin and moxifloxacin in Streptococcus pneumoniae. Wild-type strain R6 had postantibiotic effects of 2.05 ± 0.10 h (mean ± standard deviation [SD]) and 3.23 ± 0.45 h at 2.5× and 10× MIC of levofloxacin, respectively. Moxifloxacin exhibited lower effects of 0.87 ± 0.1 and 2.41 ± 0.29 h at 2.5× and 10× MIC, respectively. Fluoroquinolone-induced chromosome fragmentation was measured at equivalent postantibiotic effects for levofloxacin (2.5× MIC) and moxifloxacin (10× MIC). After 2 h of drug removal, reductions were approximately 7-fold for levofloxacin and 3-fold for moxifloxacin, without further decreases at later times. Variations in reactive oxygen species production were detected after 4 to 6 h of drug withdrawals, with decreases ≥400-fold for levofloxacin and ≥800-fold for moxifloxacin at 6 h. In accordance, after 4 to 6 h of drug withdrawal, the levofloxacin-induced upregulation of the fatCDEB operon, introducing iron in the bacteria, decreased up to 2- to 3-fold, and the moxifloxacin-induced upregulation of several genes involved in the production of pyruvate was reduced 3- to 7-fold. In accordance, lower postantibiotic effects (up to 1 h) were observed in strain R6 ΔspxB, lacking the main enzyme involved in oxygen peroxide production, than in R6. Although no change in the recovery of chromosome fragmentation was observed between R6 and R6 ΔspxB, 3.5 × 103-fold lower reactive oxygen species production was observed in R6 ΔspxB, without changes after drug removal. These results show that reactive oxygen species are the main factors directing the postantibiotic effect of levofloxacin and moxifloxacin in S. pneumoniae.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An uncharacterized member of the Gls24 protein superfamily is a putative sensor of essential amino acid availability in Streptococcus pneumoniae

  • Ferrándiz, María José
  • Cercenado, María I.
  • Domenech, Mirian
  • Tirado-Vélez, José Manuel
  • Escolano-Martínez, María S.
  • Yuste, José
  • García, Ernesto
  • Campa, Adela G. de la
  • Martín-Galiano, Antonio J.
17 p.-5 fig.-1 tab., Proteins belonging to the Gls24 superfamily are involved in survival of pathogenic Gram-positive cocci under oligotrophic conditions and other types of stress, by a still unknown molecular mechanism. In Firmicutes, this superfamily includes three different valine-rich orthologal families (Gls24A, B, C) with different potential interactive partners. Whereas the Streptococcus pneumoniae Δgls24A deletion mutant experienced a general long growth delay, the Δgls24B mutant grew as the parental strain in the semisynthetic AGCH medium but failed to grow in the complex Todd-Hewitt medium. Bovine seroalbumin (BSA) was the component responsible for this phenotype. The effect of BSA on growth was concentration-dependent and was maintained when the protein was proteolyzed but not when heat-denatured, suggesting that BSA dependence was related to oligopeptide supplementation. Global transcriptional analyses of the knockout mutant revealed catabolic derepression and induction of chaperone and oligopeptide transport genes. This mutant also showed increased sensibility to cadmium and high temperature. The Δgls24B mutant behaved as a poor colonizer in the nasopharynx of mice and showed 20-fold competence impairment. Experimental data suggest that Gls24B plays a central role as a sensor of amino acid availability and its connection to sugar catabolism. This metabolic rewiring can be compensated in vitro, at the expenses of external oligopeptide supplementation, but reduce important bacteria skills prior to efficiently address systemic virulence traits. This is an example of how metabolic factors conserved in enterococci, streptococci, and staphylococci can be essential for survival in poor oligopeptide environments prior to infection progression., This study was supported by grants BIO2017-82951-R and SAF2017-83388 from Plan Nacional de I+D+I of the Ministry of Economy, Industry and Competitiveness, and funds from the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) (an initiative of the Instituto de Salud Carlos III)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genome-wide proximity between RNA polymerase and DNA topoisomerase I supports transcription in Streptococcus pneumoniae

  • Ferrándiz, María José
  • Hernandez, Pablo
  • Campa, Adela G. de la
21 p.-7 fig., Streptococcus pneumoniae is a major cause of disease and death that develops resistance to multiple antibiotics. DNA topoisomerase I (TopoI) is a novel pneumococcal drug target. TopoI is the sole type-I pneumococcal topoisomerase that regulates supercoiling homeostasis in this bacterium. In this study, a direct in vitro interaction between TopoI and RNA polymerase (RNAP) was detected by surface plasmon resonance. To understand the interplay between transcription and supercoiling regulation in vivo, genome-wide association of RNAP and TopoI was studied by ChIP-Seq. RNAP and TopoI were enriched at the promoters of 435 and 356 genes, respectively. Higher levels of expression were consistently measured in those genes whose promoters recruit both RNAP and TopoI, in contrast with those enriched in only one of them. Both enzymes occupied a narrow region close to the ATG codon. In addition, RNAP displayed a regular distribution throughout the coding regions. Likewise, the summits of peaks called with MACS tool, mapped around the ATG codon in both cases. However, RNAP showed a broader distribution towards ATG-downstream positions. Remarkably, inhibition of RNAP with rifampicin prevented the localization of TopoI at promoters and, vice versa, inhibition of TopoI with seconeolitsine prevented the binding of RNAP to promoters. This indicates a functional interplay between RNAP and TopoI. To determine the molecular factors responsible for RNAP and TopoI co-recruitment, we looked for DNA sequence motifs. We identified a motif corresponding to a -10-extended promoter for TopoI and for RNAP. Furthermore, RNAP was preferentially recruited to genes co-directionally oriented with replication, while TopoI was more abundant in head-on genes. TopoI was located in the intergenic regions of divergent genes pairs, near the promoter of the head-on gene of the pair. These results suggest a role for TopoI in the formation/stability of the RNAP-DNA complex at the promoter and during transcript elongation., This work was supported by the Ministerio de Economía y Competitividad [BIO2017-82951-R to AGC]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

La DNA Topoisomerasa I como diana de antimicrobianos

  • Ferrándiz, María José
  • Martín-Galiano, Antonio J.
  • García, María Teresa
  • Hernandez, Pablo
  • Campa, Adela G. de la
1 p., Los procesos celulares que necesitan el desenrollamiento de la doble hélice de DNA, como transcripción, replicación y recombinación, requieren del mantenimiento de un nivel adecuado de superenrollamiento del DNA. Éste se consigue gracias a la actividad de las topoisomerasas. En el patógeno humano Streptococcus pneumoniae las enzimas encargadas de este mantenimiento son la girasa, que introduce superenrollamiento negativo y la topoisomerasa I (topoI) que relaja el DNA.Ambas son dianas de antibióticos, la girasa de las fluoroquinolonas y la topoI de la seconeolitsina,compuesto que inhibe el crecimiento de bacterias que poseen una única topoisomerasa de tipo I,como S. pneumoniae y Mycobacterium tuberculosis. En neumococo, topoI es la principal responsable de la regulación homeostática del nivel de superenrollamiento. Los cambios topológicos generados bien por relajación o por incremento del nivel de superenrollamiento desencadenan respuestas transcripcionales globales que ponen de manifiesto la organización del genoma en dominios topológicos. Atendiendo a la respuesta transcripcional y al contenido en AT, los genes se clasifican en las siguientes categorías: regulados por superenrollamiento (con regulación positiva y con regulación negativa) y no regulados (con posición variable, con posición conservada y ricos en AT). Además, topoI desempeña un papel esencial en la transcripción del DNA. En S. pneumoniae,hemos demostrado la interacción de topoI con la RNA polimerasa in vitro y en ensayos in vivo de inmunoprecipitación de cromatina hemos determinado que ambas enzimas colocalizan en la región promotora de los genes. Todos estos resultados apuntan a topoI como una nueva diana de antimicrobianos., Trabajo financiado por el Ministerio de Economía y Competitividad, BIO2017-82951-R., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Boldine-derived Alkaloids inhibit the activity of DNA topoisomerase I and growth of Mycobacterium tuberculosis

  • García, M.T.
  • Carreño, D.
  • Tirado-Vélez, J.M.
  • Ferrándiz, M.J.
  • Rodrigues, L.
  • Gracia, B.
  • Amblar, M.
  • Ainsa, J.A.
  • de la Campa, A.G.
The spread of multidrug-resistant isolates of Mycobacterium tuberculosis requires the discovery of new drugs directed to new targets. In this study, we investigated the activity of two boldine-derived alkaloids, seconeolitsine (SCN) and N-methyl-seconeolitsine (N-SCN), against M. tuberculosis. These compounds have been shown to target DNA topoisomerase I enzyme and inhibit growth of Streptococcus pneumoniae. Both SCN and N-SCN inhibited M. tuberculosis growth at 1.95-15.6 µM, depending on the strain. In M. smegmatis this inhibitory effect correlated with the amount of topoisomerase I in the cell, hence demonstrating that this enzyme is the target for these alkaloids in mycobacteria. The gene coding for topoisomerase I of strain H37Rv (MtbTopoI) was cloned into pQE1 plasmid of Escherichia coli. MtbTopoI was overexpressed with an N-terminal 6-His-tag and purified by affinity chromatography. In vitro inhibition of MtbTopoI activity by SCN and N-SCN was tested using a plasmid relaxation assay. Both SCN and N-SCN inhibited 50% of the enzymatic activity at 5.6 and 8.4 µM, respectively. Cleavage of single-stranded DNA was also inhibited with SCN. The effects on DNA supercoiling were also evaluated in vivo in plasmid-containing cultures of M. tuberculosis. Plasmid supercoiling densities were -0.060 in cells untreated or treated with boldine, and -0.072 in 1 × MIC N-SCN treated cells, respectively, indicating that the plasmid became hypernegatively supercoiled in the presence of N-SCN. Altogether, these results demonstrate that the M. tuberculosis topoisomerase I enzyme is an attractive drug target, and that SCN and N-SCN are promising lead compounds for drug development.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis

  • García Esteban, María Teresa
  • Carreño, David
  • Tirado Vélez, José Manuel
  • Ferrándiz, María José
  • Rodrigues, Liliana
  • Gracia, Begoña
  • Amblar, Mónica
  • Ainsa, José A.
  • Gonzalez de la Campa, Adela
The spread of multidrug-resistant isolates of Mycobacterium tuberculosis requires the discovery of new drugs directed to new targets. In this study, we investigated the activity of two boldine-derived alkaloids, seconeolitsine (SCN) and N-methyl-seconeolitsine (N-SCN), against M. tuberculosis. These compounds have been shown to target DNA topoisomerase I enzyme and inhibit growth of Streptococcus pneumoniae. Both SCN and N-SCN inhibited M. tuberculosis growth at 1.95–15.6 μM, depending on the strain. In M. smegmatis this inhibitory effect correlated with the amount of topoisomerase I in the cell, hence demonstrating that this enzyme is the target for these alkaloids in mycobacteria. The gene coding for topoisomerase I of strain H37Rv (MtbTopoI) was cloned into pQE1 plasmid of Escherichia coli. MtbTopoI was overexpressed with an N-terminal 6-His-tag and purified by affinity chromatography. In vitro inhibition of MtbTopoI activity by SCN and N-SCN was tested using a plasmid relaxation assay. Both SCN and N-SCN inhibited 50% of the enzymatic activity at 5.6 and 8.4 μM, respectively. Cleavage of single-stranded DNA was also inhibited with SCN. The effects on DNA supercoiling were also evaluated in vivo in plasmid-containing cultures of M. tuberculosis. Plasmid supercoiling densities were −0.060 in cells untreated or treated with boldine, and −0.072 in 1 × MIC N-SCN treated cells, respectively, indicating that the plasmid became hypernegatively supercoiled in the presence of N-SCN. Altogether, these results demonstrate that the M. tuberculosis topoisomerase I enzyme is an attractive drug target, and that SCN and N-SCN are promising lead compounds for drug development.
Docta Complutense
Publicación Contribución de congreso (ConferenceOutput)

La DNA Topoisomerasa I como diana de antimicrobianos

  • Ferrándiz Avellano, María José
  • Martín Galiano, Antonio Javier
  • García Esteban, María Teresa
  • Hernández Valenzuela, Pablo
  • González de la Campa, Adela
Los procesos celulares que necesitan el desenrollamiento de la doble hélice de DNA, como transcripción, replicación y recombinación, requieren del mantenimiento de un nivel adecuado de superenrollamiento del DNA. Éste se consigue gracias a la actividad de las topoisomerasas. En el patógeno humano Streptococcus pneumoniae las enzimas encargadas de este mantenimiento son la girasa, que introduce superenrollamiento negativo y la topoisomerasa I (topoI) que relaja el DNA. Ambas son dianas de antibióticos, la girasa de las fluoroquinolonas y la topoI de la seconeolitsina, compuesto que inhibe el crecimiento de bacterias que poseen una única topoisomerasa de tipo I, como S. pneumoniae y Mycobacterium tuberculosis. En neumococo, topoI es la principal responsable de la regulación homeostática del nivel de superenrollamiento. Los cambios topológicos generados bien por relajación o por incremento del nivel de superenrollamiento desencadenan respuestas transcripcionales globales que ponen de manifiesto la organización del genoma en dominios topológicos. Atendiendo a la respuesta transcripcional y al contenido en AT, los genes se clasifican en las siguientes categorías: regulados por superenrollamiento (con regulación positiva y con regulación negativa) y no regulados (con posición variable, con posición conservada y ricos en AT). Además, topoI desempeña un papel esencial en la transcripción del DNA. En S. pneumoniae, hemos demostrado la interacción de topoI con la RNA polimerasa in vitro y en ensayos in vivo de inmunoprecipitación de cromatina hemos determinado que ambas enzimas colocalizan en la región promotora de los genes. Todos estos resultados apuntan a topoI como una nueva diana de antimicrobianos.